Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | CA4 | P22748 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL392504 | 0.78 | CA1 (0.36) | CA1CA2 | |
| SCHEMBL1997466 | 0.78 | CES2 (0.38) | CES2CES1 | |
| SCHEMBL23387001 | 0.75 | CA1 (0.30) | CA1CA2CA4CA12CA7 | |
| SCHEMBL1343625 | 0.75 | ALDH1A1 (0.33) | ALDH1A1CA1CA2CA4CA12 | |
| SCHEMBL97201 | 0.75 | CES2 (0.37) | CA1CA2CA4CA12CA7 | |
| SCHEMBL3182645 | 0.75 | ERN1 (0.40) | CES2CES1 | |
| SCHEMBL5704438 | 0.73 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL16469385 | 0.71 | MAPT (0.32) | MAPT | |
| SCHEMBL16546180 | 0.71 | ERN1 (0.32) | — | |
| SCHEMBL474389 | 0.71 | INPPL1 (0.32) | CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8952083-B2 | Fluorocopolymer composition and its production process | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-02-10 | — | — | US | claimed |
| EP-4397672-A1 | COMPOUND AND LABELED BIOMATERIAL USING SAME | FUJIFILM Corporation (JP) | 2024-07-10 | — | — | EP | disclosed |
| US-12018159-B2 | Ultra bright dimeric or polymeric dyes and methods for preparation of the same | Sony Group Corporation (JP) | 2024-06-25 | — | — | US | disclosed |
| US-11827661-B2 | Water soluble fluorescent or colored dyes comprising conjugating groups | Sony Group Corporation (JP) | 2023-11-28 | — | — | US | disclosed |
| US-20220001022-A1 | Immunoconjugates Targeting HER2 | BOLT BIOTHERAPEUTICS, INC. (US) | 2022-01-06 | — | — | US | disclosed |
| US-11110178-B2 | Antibody adjuvant conjugates | THE BOARD OF TRUSTEES OF THE LELAND STANDFORD JUNIOR UNIVERSITY (US) | 2021-09-07 | — | — | US | disclosed |
| US-20210170043-A1 | DC-SIGN ANTIBODY CONJUGATES COMPRISING STING AGONISTS | CHINOOK THERAPEUTICS, INC. | 2021-06-10 | — | — | US | disclosed |
| US-20200206357-A1 | ANTIBODY ADJUVANT CONJUGATES | BOLT BIOTHERAPEUTICS, INC. | 2020-07-02 | — | — | US | disclosed |
| US-10675358-B2 | Antibody adjuvant conjugates | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2020-06-09 | — | — | US | disclosed |
| US-10464969-B2 | Amatoxin derivatives and conjugates thereof as inhibitors of RNA polymerase | NOVARTIS AG (CH) | 2019-11-05 | — | — | US | disclosed |
| US-20190144504-A1 | AMATOXIN DERIVATIVES AND CONJUGATES THEREOF AS INHIBITORS OF RNA POLYMERASE | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. | 2019-05-16 | — | — | US | disclosed |
| US-8952083-B2 | Fluorocopolymer composition and its production process | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-02-10 | — | — | US | disclosed |
| US-8748097-B1 | Identification of agents for treating calcium disorders and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2014-06-10 | — | — | US | disclosed |
| US-8747535-B1 | Solid ink compositions comprising crystalline-amorphous mixtures | XEROX CORPORATION (US) | 2014-06-10 | — | — | US | disclosed |
| CN-102186921-B | Fluorine-containing copolymer composition and process for production thereof | ASAHI GLASS CO LTD | 2014-01-15 | — | — | CN | disclosed |
| EP-2338935-B1 | FLUORINE-CONTAINING COPOLYMER COMPOSITION AND PROCESS FOR PRODUCTION THEREOF | ASAHI GLASS CO LTD (JP) | 2012-12-12 | — | — | EP | disclosed |
| CN-102186921-A | Fluorine-containing copolymer composition and process for production thereof | ASAHI GLASS CO LTD | 2011-09-14 | — | — | CN | disclosed |
| US-20110172336-A1 | FLUOROCOPOLYMER COMPOSITION AND ITS PRODUCTION PROCESS | ASAHI GLASS COMPANY, LIMITED (JP) | 2011-07-14 | — | — | US | disclosed |
| EP-2338935-A1 | FLUORINE-CONTAINING COPOLYMER COMPOSITION AND PROCESS FOR PRODUCTION THEREOF | ASAHI GLASS COMPANY, LIMITED (JP) | 2011-06-29 | — | — | EP | disclosed |
| US-20070299204-A1 | Polymerizable Composition for Forming Optical Device, Optical Device and Method for Producing Optical Device | FUJIFILM CORPORATION (JP) | 2007-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10464969-B2 | Amatoxin derivatives and conjugates thereof as inhibitors of RNA polymerase | RNGTT, RNASE1, RNMT | ALDH1A1 3142/4885CA1 2515/4885CA2 3395/4885 |
| US-20200206357-A1 | ANTIBODY ADJUVANT CONJUGATES | FCGR1A, FCGR3B, FCGR2A | ALDH1A1 978/4885CA1 1037/4885CA2 2977/4885 |
| US-10675358-B2 | Antibody adjuvant conjugates | FCGR1A, FCGR3B, FCGR2A | ALDH1A1 978/4885CA1 1037/4885CA2 2977/4885 |
| US-20210170043-A1 | DC-SIGN ANTIBODY CONJUGATES COMPRISING STING AGONISTS | STING1, TLR9, TLR3 | ALDH1A1 4425/4885CA1 4619/4885CA2 4384/4885 |
| US-20190144504-A1 | AMATOXIN DERIVATIVES AND CONJUGATES THEREOF AS INHIBITORS OF RNA POLYMERASE | RNGTT, RNASE1, RNMT | ALDH1A1 3142/4885CA1 2515/4885CA2 3395/4885 |
| US-11827661-B2 | Water soluble fluorescent or colored dyes comprising conjugating groups | CHRM1, CHRM2, H1-0 | ALDH1A1 965/4885CA1 2197/4885CA2 3774/4885 |
| US-20220001022-A1 | Immunoconjugates Targeting HER2 | ERBB2, EGFR, FCGR2A | ALDH1A1 4387/4885CA1 1407/4885CA2 405/4885 |
| US-11110178-B2 | Antibody adjuvant conjugates | FCGR1A, FCGR3B, FCGR2A | ALDH1A1 978/4885CA1 1037/4885CA2 2977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.